University of Pennsylvania Health System in Philadelphia announced the appointment of D. Gary Gilliland, MD, as its first vice president for precision medicine.
Most recently, Dr. Gilliland served as senior vice president of Merck Research Laboratories and head of Merck's oncology franchise. In his new role, Dr. Gilliland will work with the health system's top leaders to create a national model for the delivery of personalized medicine to patients.
More Articles on Pennsylvania Executive Moves:
Thomas Jefferson University Hospitals Names Dr. Stephen Klasko CEO
Ellwood City Hospital CEO Ray Beck Resigns
Summit Health COO Patrick O'Donnell Promoted to CEO